Regulatory and Data Privacy Issues relating to Real World Evidence
It is well known that digital health technologies have the potential to generate and record a large amount of data, [...]
New InformED Podcast on Health Equity, Disparities, and Literacy Now Available
A new episode of the International Society for Medical Publication Professionals’ InformED podcast series is now available. Sponsored by MedThink [...]
Dial back drug-pricing
Democrats dial back drug-pricing plans to win over moderates It’s a sign the drug industry is bending a potential compromise [...]
Caps on Rx medication costs are part of Federal regulations that make drugs cost less in Canada
VICTORIA, British Columbia — Americans pay considerably more for medications than citizens from other countries with similar median household incomes [...]
Nonprofit linked to PhRMA behind ads opposing drug pricing changes | News & Features
WASHINGTON — The nonprofit organization behind a wide-reaching ad campaign against allowing Medicare to negotiate drug prices has deep ties [...]
LA Kelley Communications Partners with MedPanel To Provide Market Research in Bleeding Disorder Community
GEORGETOWN, Mass. LA Kelley Communications, Inc. announces a new partnership with MedPanel, Inc. to provide in-depth market research in the [...]
Op-Ed: Prescription drug pricing needs government oversight
Op-Ed: Prescription drug pricing needs government oversight Television ads for prescription drugs that treat diabetes feature soaring, triumphant music as [...]
What the Stalemate on Capitol Hill Means for Your Drug Prices
Share Sarah Jane Tribble, Kaiser Health News As President Joe Biden’s government overhaul stalls in Congress, tensions are mounting over [...]
Operating losses at Oxford based Sensyne Health deepen, but collaborations continue to grow
Sensyne Health, the Oxford Science Park based ethical clinical AI company has reported that while operating losses deepened to £29.9 [...]
Major Corporations Weigh In As Drug Pricing Debate Continues
Major American corporations are split in half as the drug pricing debate continues. One camp, led by the U.S. Chamber [...]
New Report Estimates 30% in CMS Drug Savings Using Domestic Reference Pricing Model
A new report estimates that Medicare could have seen savings as high as 30% had a domestic reference pricing approach [...]
Prescription Drug Pricing Reform Could Mean Discounts on AAP Drugs Pending Clinical Proof
As multidisciplinary stakeholders consider how to reform the prescription drug pricing structure, one recent proposal is gaining traction. Drugs pushed [...]
EMA Data Expert Discusses Gaps in RWE Framework
The European Medicines Agency (EMA) has recognized gaps in guidelines on real world evidence (RWE) submissions. The EMA’s Xavier Kurz [...]
Upcoming ISPOR Webinar on Value in Healthcare Decision-Making
The International Society for Pharmacoeconomics and Outcomes (ISPOR) will hold a webinar on decision-making in healthcare on October 26th at 11:00 [...]
Over Half of US Voters Want Gov’t. to Negotiate Drug Prices for Elderly Americans – Poll
Over Half Of US Voters Want Gov't. To Negotiate Drug Prices For Elderly Americans - Poll Umer Jamshaid 12 hours [...]
Democrats dial back drug-pricing plans to win over moderates
Democrats dial back drug-pricing plans to win over moderates It’s a sign the drug industry is bending a potential compromise [...]
Precision Medicine Market Size, Growth & Global Forecast Report to 2027
30/set/2021 12:04:00 [Bhairavi](/utenti/25065/1) [Contatta l'autore](/comunicati/aziende/tecnologia/731312-contatta.html) COVID-19 Impact Analysis on Precision Medicine Market report published by Value Market Research provides a [...]
Register Now for Upcoming Regulatory RWE Webinar
Flatiron Health will hold a webinar highlighting how real world evidence (RWE) studies can aid in obtaining regulatory approval. Speakers [...]
NICE Technical Director Discusses RWE and HEOR Careers and Key Trends
Jacoline Bouvy of the National Institute for Health and Care Excellence (NICE) discussed key trends in health economics and outcomes [...]
How Can NMAs and ITCs Add Value to HTAs?
The Evidence Base recently interviewed Dutch researcher Daan Reid. He shared his thoughts on health technology assessments (HTAs) and improving [...]
Opinion: As a congressmember, here’s why I can’t support the Lower Drug Costs Now Act
Opinion: As a congressmember, here’s why I can’t support the Lower Drug Costs Now Act Rep. Scott Peters is proposing [...]
Patient Engagement Solutions Market worth $19.3 billion by 2025 | Leading Players are McKesson Corporation (US), Allscripts (US), Ibm (US)
McKesson Corporation (US), Allscripts (US), IBM (US), AdvancedMD (US), Cerner Corporation (US), Epic Systems Corporation (US) are the dominating players [...]
Strategic Decisions Group Elects New Partner to Lead Life Sciences Practice in North America
Decision makers in the life sciences industry are constantly searching for new ways to create value ... SDG is at [...]
Life Science Analytics Software Market Size Estimated to Grow at a CAGR of 13.44% During the Forecast Period 2021-2027
Market Study Report recently added a new title on 2021-2027 Global Life Science Analytics Software Market Report from its database. [...]
Catalyst wins reversal in orphan exclusivity court battle with FDA
A US appeals court on Thursday afternoon overturned a prior FDA court win, saying that the agency never should’ve approved [...]